PURPOSE: The aim of this preliminary study was to determine the possible relationship between alkaline phosphatase (ALP) levels in the gingival crevicular fluid (GCF) and periodontal disease in men with hypergonadotropic hypogonadism (HH). MATERIALS AND METHODS: A total of 41 patients were divided into four groups. 9 with HH and periodontitis (P/HH), 11 with HH and gingivitis (G/HH), 12 with systemically healthy and periodontally healthy (H/C) and 9 with systemically healthy and periodontitis (P/C). The clinical evaluation of patients was based on the following parameters; the plaque index (PI), gingival index (GI), probing depths (PD) and attachment level (AL). The levels of ALP in the GCF were measured by enzyme-linked immunosorbent assay (ELISA). RESULTS: No significant difference could be detected in the mean clinical parameter data between the P/HH and P/C groups (p > 0.05). The periodontitis patients in both groups (P/C and P/HH) had higher mean probing depths than the H/C and G/HH patients (p < 0.001). The concentrations and total amounts of ALP in the GCF were significantly higher in both periodontitis groups compared to healthy and gingivitis groups (p < 0.01). The serum ALP levels were significantly higher in the P/HH group when compared to the other groups (p < 0.001). CONCLUSION: The findings of this study suggested that HH could be implicated as a contributing factor to the progress of periodontal disease.
Adolescent ; Adult ; Alkaline Phosphatase/*metabolism ; Gingival Crevicular Fluid/*enzymology ; Humans ; Hypogonadism/diagnosis/*enzymology ; Male ; Periodontium/*enzymology

OBJECTIVETo study the effect of smoking on the periodontium and level of aspartate aminotransferase in gingival cervical fluid (GCF-AST).

METHODSA proportion matched case-control filtration was performed in examined population, college students, outpatients from 1999 May to 2001 March 115 smokers aged from 23 to 65 years (102 men and 13 women) and 90 non-smokers aged from 25 to 70 years (80 men and 10 women) were chosen. Debris index (DI), calculus index (CI), periodontal disease index (PDI), GCF-AST were measured.

RESULTSNo obvious differences were observed in DI in smokers (0 degrees, 27.2%; 5 degrees, 5.0%) and non-smokers (0 degrees, 27.8%; 5 degrees, 4.2%),whereas obvious differences were found in CI in smokers and non-smokers. The percentages of patients without calculus were lower in smokers (9.8%) than in non-smokers (20.0%). The percentages of patients with weighty calculus were higher in smokers (25.4%) than in non-smokers (12.8%). The PDI values in smokers were higher than in non-smokers. The percentages of their normal periodontium were lower in smokers (9.6%) than in non-smokers (20.8%). The percentages of their periodontitis were higher in smokers (38.5%) than in non-smokers (25.8%). The smoking quantity were positively related to periodontitis (P < 0.001). No obvious differences were found in the level of GCF-AST with same PDI (P > 0.05).

CONCLUSIONSmoking is considered as one of the risk factors in the prevalence of periodontal disease, but may not have any direct effect on GCF-AST.

Adult ; Aged ; Aspartate Aminotransferases ; metabolism ; Case-Control Studies ; Female ; Gingival Crevicular Fluid ; enzymology ; Humans ; Male ; Middle Aged ; Periodontitis ; etiology ; Periodontium ; enzymology ; Smoking ; adverse effects

OBJECTIVETo investigate the influence of Bushenguchiwan on expression of matrix metalloproteinase-13 (MMP-13) in periodontium of rats with experimental periodontitis.

METHODSThe model of experimental periodontitis of rats was established and treated by Bushenguchiwan with different doses. The periodontal tissues from groups of different doses were immunohistochemically stained by antibody of MMP-13. The expression of MMP-13 was examined and semi-quantitative analysis of signals performed by integrated absorbance.

RESULTSMMP-13 was intensely positive in gingival epithelial cells and periodontal fibroblasts in periodontitis models and negative in normal rat periodontal tissues. After 30 days of Bushenguchiwan treatment with high dose, middle dose and low dose, the expression of MMP-13 (2.9103 ± 0.5534, 3.6588 ± 0.4330, 4.4550 ± 0.4255) was down-regulated respectively compared with model rats (5.3233 ± 0.7993), P < 0.05. After 60 days of treatment the expression of MMP-13 (2.1855 ± 0.5381, 2.8558 ± 0.4759, 3.8980 ± 0.5885) was down-regulated more significantly. with model rats (6.2693 ± 0.4538), P < 0.05.

CONCLUSIONSBushenguchiwan could down-regulate the expression of MMP-13 in rats' periodontium and the high dose group had better effect.

Animals ; Dose-Response Relationship, Drug ; Drugs, Chinese Herbal ; administration & dosage ; therapeutic use ; Epithelial Cells ; enzymology ; Female ; Fibroblasts ; enzymology ; Gingiva ; cytology ; enzymology ; Male ; Matrix Metalloproteinase 13 ; metabolism ; Periodontitis ; drug therapy ; enzymology ; microbiology ; Periodontium ; cytology ; enzymology ; Porphyromonas gingivalis ; Random Allocation ; Rats ; Rats, Sprague-Dawley